Market Research Logo

Global Angina Pectoris Drugs Market 2017-2021

About Angina Pectoris Drugs

Angina is a type of chest pain or discomfort caused due to a coronary heart disease, specifically due to reduced blood flow to the heart. For angina pectoris drugs market, beta blockers remain the most preferred line of treatment. However, the treatment market witnesses a strong presence of other drug classes such as calcium channel blockers. Though the market is fragmented, large players such as AstraZeneca, Gilead, Novartis, and Pfizer hold significant positions.

Technavio’s analysts forecast the global angina pectoris drugs market to grow at a CAGR of 4.05% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global angina pectoris drugs market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Angina Pectoris Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Gilead
  • Novartis
  • Pfizer
Other prominent vendors
  • ABayer HealthCare
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Merck
  • Mylan
  • Teva Pharmaceutical
Market driver
  • Increase in chronic diseases
  • For a full, detailed list, view our report
Market challenge
  • Highly genericized market
  • For a full, detailed list, view our report
Market trend
  • Launch of novel pharmacologic agents
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Major angina types
      • Table Causes, symptoms, and risk factors for angina pectoris
      • Table Diagnosis and treatment of angina pectoris
  • Market landscape
    • Market overview
      • Table Global angina pectoris drugs market snapshot
      • Table Global angina pectoris drugs market 2016-2021 ($ millions)
      • Table Opportunity analysis of the global angina pectoris drugs market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Pipeline molecules by key vendors 2016
    • Table Key clinical trials
  • Market segmentation by drug class
    • Table Segmentation of global angina pectoris market by drug class
    • Table Segmentation of global angina pectoris market by drug class 2016 and 2021
    • Beta blockers
      • Table Global angina pectoris drugs market by beta blockers 2016-2021 ($ millions)
      • Table Common beta blockers used in cardiovascular disorders
      • Table Adverse effects of beta-blockers
    • Calcium channel blockers
      • Table Global angina pectoris drugs market by calcium channel blockers 2016-2021 ($ millions)
      • Table Common calcium channel blockers used for angina pectoris
      • Table Antianginal effects of calcium channel blockers
      • Table Adverse effects of calcium channel blockers
    • Nitrates
      • Table Nitrates for treatment of angina pectoris
      • Table Global angina pectoris drugs market by nitrates 2016-2021 ($ millions)
      • Table Effect of nitrates on cardiovascular system
      • Table Nitroglycerine used for the treatment and prevention of angina pectoris
    • Angiotensin-converting enzyme inhibitors
      • Table Global angina pectoris drugs market by angiotensin-converting enzyme inhibitors 2016-2021 ($ millions)
      • Table Adverse effects of angiotensin-converting enzyme inhibitors
    • Others
      • Table Other drug classes used for the treatment of angina pectoris
      • Table Global angina pectoris drugs market by others 2016-2021 ($ millions)
      • Table Antiplatelet agents used for treatment of angina pectoris
      • Table Anti-ischemic agent used in treatment of angina pectoris
  • Geographical segmentation
    • Market overview based on geography
      • Table Global angina pectoris drugs market share by geography 2016 and 2021
      • Table Global angina pectoris drugs market by geography 2016-2021 ($ millions)
    • Angina pectoris drugs market in Americas
      • Table Market scenario in Americas
      • Table Angina pectoris drugs market in Americas 2016-2021 ($ millions)
    • Angina pectoris drugs market in EMEA
      • Table Market scenario in EMEA
      • Table Angina pectoris drugs market in EMEA 2016-2021 ($ millions)
    • Angina pectoris market in APAC
      • Table Market scenario in APAC
      • Table Angina pectoris drugs market in APAC 2016-2021 ($ millions)
      • Table Top Asian countries in terms of population with diabetes
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table World population by age group: 2015-2050 (million)
      • Table Percentage of population aged 60 and above by region 2015-2050
      • Table Major complications of diabetes
      • Table Global obesity facts 2014
    • Market challenges
  • Market trends
    • Launch of novel pharmacologic agents
    • Genomic medicines
    • Growing strategic alliances
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global angina pectoris drugs market
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Key highlights
      • Table AstraZeneca: Strength assessment
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
    • Gilead
      • Table Gilead: Key highlights
      • Table Gilead: Strength assessment
      • Table Gilead: Strategy assessment
      • Table Gilead: Opportunity assessment
    • Novartis
      • Table Novartis: Key highlights
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report